1Bach, JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347, 911–920.
2Metz, M & Maurer, M (2007) Mast cells – key effector cells in immune responses. Trends Immunol 28, 234–241.
3Galli, SJ, Nakae, S & Tsai, M (2005) Mast cells in the development of adaptive immune responses. Nat Immunol 6, 135–142.
4Metcalfe, DD, Baram, D & Mekori, YA (1997) Mast cells. Physiol Rev 77, 1033–1079.
5Stone, KD, Prussin, C & Metcalfe, DD (2010) IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 125, S73–S80.
6Chai, OH, Han, EH, Lee, HK, et al. (2011) Mast cells play a key role in Th2 cytokine-dependent asthma model through production of adhesion molecules by liberation of TNF-alpha. Exp Mol Med 43, 35–43.
7Pettipher, R, Hansel, TT & Armer, R (2007) Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases. Nat Rev Drug Discov 6, 313–325.
9Taube, C, Wei, X, Swasey, CH, et al. (2004) Mast cells, Fc epsilon RI, and IL-13 are required for development of airway hyperresponsiveness after aerosolized allergen exposure in the absence of adjuvant. J Immunol 172, 6398–6406.
10Brandt, EB, Munitz, A, Orekov, T, et al. (2009) Targeting IL-4/IL-13 signaling to alleviate oral allergen-induced diarrhea. J Allergy Clin Immunol 123, 53–58.
11Calder, PC (1997) n-3 Polyunsaturated fatty acids and immune cell function. Adv Enzyme Regul 37, 197–237.
12Calder, PC (2006) Polyunsaturated fatty acids and inflammation. Prostaglandins Leukot Essent Fatty Acids 75, 197–202.
13Stulnig, TM (2003) Immunomodulation by polyunsaturated fatty acids: mechanisms and effects. Int Arch Allergy Immunol 132, 310–321.
14Prescott, SL & Calder, PC (2004) n-3 Polyunsaturated fatty acids and allergic disease. Curr Opin Clin Nutr Metab Care 7, 123–129.
15Simopoulos, AP (2002) Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 21, 495–505.
16Calder, PC & Grimble, RF (2002) Polyunsaturated fatty acids, inflammation and immunity. Eur J Clin Nutr 56, Suppl. 3, S14–S19.
17Black, PN & Sharpe, S (1997) Dietary fat and asthma: is there a connection? Eur Respir J 10, 6–12.
18Lauritzen, L, Kjaer, TM, Fruekilde, MB, et al. (2005) Fish oil supplementation of lactating mothers affects cytokine production in 2 1/2-year-old children. Lipids 40, 669–676.
19Dunstan, JA, Mori, TA, Barden, A, et al. (2003) Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. J Allergy Clin Immunol 112, 1178–1184.
20Furuhjelm, C, Warstedt, K, Larsson, J, et al. (2009) Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatr 98, 1461–1467.
21Furuhjelm, C, Warstedt, K, Fageras, M, et al. (2011) Allergic disease in infants up to 2 years of age in relation to plasma omega-3 fatty acids and maternal fish oil supplementation in pregnancy and lactation. Pediatr Allergy Immunol 22, 505–514.
22Duchen, K, Yu, G & Bjorksten, B (1998) Atopic sensitization during the first year of life in relation to long chain polyunsaturated fatty acid levels in human milk. Pediatr Res 44, 478–484.
23Kankaanpaa, P, Nurmela, K, Erkkila, A, et al. (2001) Polyunsaturated fatty acids in maternal diet, breast milk, and serum lipid fatty acids of infants in relation to atopy. Allergy 56, 633–638.
24Miles, EA & Calder, PC (1998) Modulation of immune function by dietary fatty acids. Proc Nutr Soc 57, 277–292.
25James, MJ, Gibson, RA & Cleland, LG (2000) Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 71, 343S–348S.
26Kelley, DS (2001) Modulation of human immune and inflammatory responses by dietary fatty acids. Nutrition 17, 669–673.
27Kim, JY & Ro, JY (2005) Signal pathway of cytokines produced by reactive oxygen species generated from phorbol myristate acetate-stimulated HMC-1 cells. Scand J Immunol 62, 25–35.
28Swindle, EJ & Metcalfe, DD (2007) The role of reactive oxygen species and nitric oxide in mast cell-dependent inflammatory processes. Immunol Rev 217, 186–205.
29Wong, SW, Kwon, MJ, Choi, AM, et al. (2009) Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J Biol Chem 284, 27384–27392.
30Suzuki, Y, Yoshimaru, T, Matsui, T, et al. (2003) Fc epsilon RI signaling of mast cells activates intracellular production of hydrogen peroxide: role in the regulation of calcium signals. J Immunol 171, 6119–6127.
31Nilsson, G, Blom, T, Kusche-Gullberg, M, et al. (1994) Phenotypic characterization of the human mast-cell line HMC-1. Scand J Immunol 39, 489–498.
32Bligh, EG & Dyer, WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37, 911–917.
33Willemsen, LE, Koetsier, MA, Balvers, M, et al. (2008) Polyunsaturated fatty acids support epithelial barrier integrity and reduce IL-4 mediated permeability in vitro. Eur J Nutr 47, 183–191.
34Nakano, N, Nakao, A, Uchida, T, et al. (2005) Effects of arachidonic acid analogs on FcepsilonRI-mediated activation of mast cells. Biochim Biophys Acta 1738, 19–28.
35Teshima, R, Amano, F, Nakamura, R, et al. (2007) Effects of polyunsaturated fatty acids on calcium response and degranulation from RBL-2H3 cells. Int Immunopharmacol 7, 205–210.
36Calder, PC, Yaqoob, P, Harvey, DJ, et al. (1994) Incorporation of fatty acids by concanavalin A-stimulated lymphocytes and the effect on fatty acid composition and membrane fluidity. Biochem J 300, 509–518.
37Stubbs, CD & Smith, AD (1984) The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim Biophys Acta 779, 89–137.
38van den Elsen, LW, Garssen, J & Willemsen, LE (2012) Long chain n-3 polyunsaturated fatty acids in the prevention of allergic and cardiovascular disease. Curr Pharm Des 18, 2375–2392.
39Gilfillan, AM & Tkaczyk, C (2006) Integrated signalling pathways for mast-cell activation. Nat Rev Immunol 6, 218–230.
40Stelekati, E, Orinska, Z & Bulfone-Paus, S (2007) Mast cells in allergy: innate instructors of adaptive responses. Immunobiology 212, 505–519.
41Obata, T, Nagakura, T, Masaki, T, et al. (1999) Eicosapentaenoic acid inhibits prostaglandin D2 generation by inhibiting cyclo-oxygenase-2 in cultured human mast cells. Clin Exp Allergy 29, 1129–1135.
42Faveeuw, C, Gosset, P, Bureau, F, et al. (2003) Prostaglandin D2 inhibits the production of interleukin-12 in murine dendritic cells through multiple signaling pathways. Eur J Immunol 33, 889–898.
43Gosset, P, Bureau, F, Angeli, V, et al. (2003) Prostaglandin D2 affects the maturation of human monocyte-derived dendritic cells: consequence on the polarization of naive Th cells. J Immunol 170, 4943–4952.
44Barnes, N, Pavord, I, Chuchalin, A, et al. (2012) A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma. Clin Exp Allergy 42, 38–48.
45Berry, M, Brightling, C, Pavord, I, et al. (2007) TNF-alpha in asthma. Curr Opin Pharmacol 7, 279–282.
46Corren, J (2011) Cytokine inhibition in severe asthma: current knowledge and future directions. Curr Opin Pulm Med 17, 29–33.
47Weise, C, Hilt, K, Milovanovic, M, et al. (2011) Inhibition of IgE production by docosahexaenoic acid is mediated by direct interference with STAT6 and NFkappaB pathway in human B cells. J Nutr Biochem 22, 269–275.
48Dunstan, JA, Mori, TA, Barden, A, et al. (2003) Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy. Clin Exp Allergy 33, 442–448.
49Cho, KJ, Seo, JM, Lee, MG, et al. (2010) BLT2 is upregulated in allergen-stimulated mast cells and mediates the synthesis of Th2 cytokines. J Immunol 185, 6329–6337.
50Fisher, M, Levine, PH, Weiner, BH, et al. (1990) Dietary n-3 fatty acid supplementation reduces superoxide production and chemiluminescence in a monocyte-enriched preparation of leukocytes. Am J Clin Nutr 51, 804–808.
51Fletcher, MP & Ziboh, VA (1990) Effects of dietary supplementation with eicosapentaenoic acid or gamma-linolenic acid on neutrophil phospholipid fatty acid composition and activation responses. Inflammation 14, 585–597.
52Hubbard, NE, Somers, SD & Erickson, KL (1991) Effect of dietary fish oil on development and selected functions of murine inflammatory macrophages. J Leukoc Biol 49, 592–598.
53Joe, B & Lokesh, BR (1994) Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim Biophys Acta 1224, 255–263.
54Thompson, PJ, Misso, NL, Passarelli, M, et al. (1991) The effect of eicosapentaenoic acid consumption on human neutrophil chemiluminescence. Lipids 26, 1223–1226.
55Berger, A, German, JB, Chiang, BL, et al. (1993) Influence of feeding unsaturated fats on growth and immune status of mice. J Nutr 123, 225–233.
56Yaqoob, P & Calder, P (1995) Effects of dietary lipid manipulation upon inflammatory mediator production by murine macrophages. Cell Immunol 163, 120–128.
57Schmutzler, S, Bachmann, L, Fuhrmann, H, et al. (2010) PUFA-dependent alteration of oxidative parameters of a canine mastocytoma cell line. Acta Vet Hung 58, 453–464.
58Zhang, X, Dong, F, Ren, J, et al. (2005) High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex. Exp Neurol 191, 318–325.
59De Caterina, R, Bernini, W, Carluccio, MA, et al. (1998) Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids. J Lipid Res 39, 1062–1070.
60Sausenthaler, S, Koletzko, S, Schaaf, B, et al. (2007) Maternal diet during pregnancy in relation to eczema and allergic sensitization in the offspring at 2 y of age. Am J Clin Nutr 85, 530–537.
61Hundley, TR, Prasad, AR & Beaven, MA (2001) Elevated levels of cyclooxygenase-2 in antigen-stimulated mast cells is associated with minimal activation of p38 mitogen-activated protein kinase. J Immunol 167, 1629–1636.
62Hirasawa, N, Izumi, S, Linwong, W, et al. (2003) Inhibition by dexamethasone of interleukin 13 production via glucocorticoid receptor-mediated inhibition of c-Jun phosphorylation. FEBS Lett 554, 489–493.
63Corren, J, Busse, W, Meltzer, EO, et al. (2010) A randomized, controlled, phase 2 study of AMG 317, an IL-4Ralpha antagonist, in patients with asthma. Am J Respir Crit Care Med 181, 788–796.